1. EBEACOPP WITH OR WITHOUT RITUXIMAB IN INTERIM‐PET‐POSITIVE ADVANCED‐STAGE HODGKIN LYMPHOMA: UPDATED RESULTS OF THE INTERNATIONAL, RANDOMIZED PHASE 3 GHSG HD18 TRIAL. (June 2017) Authors: Borchmann, P.; Goergen, H.; Kobe, C.; Eichenauer, D.; Greil, R.; Lohri, A.; Novak, U.; Markova, J.; Beck, H.; Meissner, J.; Zijlstra, J.M.; Ostermann, H.; Feuring‐Buske, M.; Dierlamm, J.; Eich, H.; Baues, C.; Rosenwald, A.; Fuchs, M.; Diehl, V.; Kuhnert, G. Journal: Hematological oncology Issue: Volume 35(2017)Supplement 2 Page Start: 65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗